STOCK TITAN

Lensar Stock Price, News & Analysis

LNSR NASDAQ

Company Description

About Lensar Inc (LNSR)

Lensar Inc is a commercial-stage medical device company that has pioneered advanced femtosecond laser technology in the realm of refractive cataract surgery. Leveraging breakthrough innovations in augmented reality imaging and 3D ocular visualization, the company develops and markets state-of-the-art laser systems designed specifically for optimizing surgical precision and delivering consistent, reproducible outcomes in cataract procedures.

Core Technology and Innovation

The company’s laser system is built around an integrated platform that combines rapid dual-modality laser performance with proprietary imaging and software solutions. At its heart lies a unique augmented reality™ system that reconstructs high-resolution, three-dimensional ocular images in a single scan. This technology enables surgeons to plan and execute precise incisions and treatments with unmatched accuracy, thereby elevating the standards of premium cataract surgery. Designed exclusively for refractive cataract procedures, every component of the system is meticulously engineered to meet the rigorous demands of modern ophthalmic surgery.

Business Model and Revenue Generation

Lensar Inc generates revenue through a commercial model that encompasses direct sales of its advanced laser systems, consumable components essential for each procedure, and service and support offerings. The company’s product portfolio is structured to provide not only the hardware but also the enhanced software capabilities—such as the Streamline® system—which supports surgeons in achieving predictable visual outcomes and operational efficiencies. This integrated model underscores the company’s commitment to efficiency, simplicity, and precision in the treatment process.

Operational Excellence and Market Presence

With a carefully built distribution network, Lensar Inc has achieved significant geographic penetration, with its primary markets including the United States, Europe, and Asia. The company maintains a robust presence in high-value markets known for their premium healthcare services. Its operations are underpinned by rigorous R&D and an ongoing commitment to clinical education, allowing the firm to remain at the forefront of technological advances in cataract surgery.

Differentiation in a Competitive Landscape

Lensar Inc distinguishes itself from competitors by offering a laser system that is the only one purpose-built for refractive cataract surgery. Unlike other femtosecond devices repurposed from other surgical applications, Lensar’s system is designed from the ground up with the specific challenges of cataract and astigmatism management in mind. This specialization is further enhanced by its proprietary imaging and procedural guidance technologies, which provide clear, real-time data that equips surgeons with the tools for optimal procedural outcomes.

Technological Integration and Surgical Support

The company’s platform goes beyond simple laser delivery. It integrates advanced imaging, measurement, and guidance systems that allow for a one-scan acquisition of high-resolution ocular images. This technological integration simplifies procedure planning and reduces the overall complexity of the surgical workflow. By bridging the gap between digital innovation and clinical practice, Lensar’s systems enhance both the efficiency and effectiveness of cataract surgery, making high-quality outcomes more accessible across varied healthcare settings.

Commitment to Quality and Clinical Impact

Lensar Inc is driven by a vision to revolutionize the approach to cataract surgery, making it more precise and patient-centric. The system’s design emphasizes reproducibility, process optimization, and the enhancement of visual outcomes for patients. The company’s solutions offer tangible benefits in terms of reduced surgical time, minimized risk, and enhanced overall efficiency within the procedure room, contributing to its reputation for clinical reliability and excellence.

Industry Recognition and Future-readiness

Through its relentless pursuit of innovation, Lensar Inc has established a niche that reflects deep expertise in both laser technology and ophthalmic surgery. The customization of its platform for the specific demands of cataract and astigmatism procedures reinforces its authority in the medical device field. While remaining neutral and focused on delivering factual information, the company demonstrates an enduring commitment to supporting the surgical community with state-of-the-art technological tools and comprehensive product support.

This comprehensive, investors-focused overview of Lensar Inc highlights its strategic approach to combining advanced laser technology with sophisticated imaging systems, setting a strong foundation for enhanced surgical precision in the treatment of cataracts. It remains a crucial point of reference for understanding the company's business model, operations, and significant position within the medical device industry.

Stock Performance

$—
0.00%
0.00
Last updated:
367.67 %
Performance 1 year
$162.6M
Market Cap
11.8M
Shares outstanding

SEC Filings

No SEC filings available for Lensar.

Financial Highlights

$13,539,000
Revenue (TTM)
-$1,502,000
Net Income (TTM)
-$0.13
Diluted EPS (TTM)
$3,153,000
Operating Cash Flow
-11.09%
Net Profit Margin
-9.20%
Oper. Profit Margin

Upcoming Events

June 1, 2025
Acquisition closing
March 3, 2026
25% stock options vest

Frequently Asked Questions

What is the current stock price of Lensar (LNSR)?

The current stock price of Lensar (LNSR) is $14.03 as of April 28, 2025.

What is the market cap of Lensar (LNSR)?

The market cap of Lensar (LNSR) is approximately 162.6M.

What is the revenue (TTM) of Lensar (LNSR) stock?

The trailing twelve months (TTM) revenue of Lensar (LNSR) is $13,539,000.

What is the net income of Lensar (LNSR)?

The trailing twelve months (TTM) net income of Lensar (LNSR) is -$1,502,000.

What is the earnings per share (EPS) of Lensar (LNSR)?

The diluted earnings per share (EPS) of Lensar (LNSR) is -$0.13 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Lensar (LNSR)?

The operating cash flow of Lensar (LNSR) is $3,153,000.

What is the profit margin of Lensar (LNSR)?

The net profit margin of Lensar (LNSR) is -11.09%.

What is the operating margin of Lensar (LNSR)?

The operating profit margin of Lensar (LNSR) is -9.20%.

What is the gross margin of Lensar (LNSR)?

The gross profit margin of Lensar (LNSR) is 46.28%.

What is the current ratio of Lensar (LNSR)?

The current ratio of Lensar (LNSR) is 3.37, indicating the company's ability to pay short-term obligations.

What is the gross profit of Lensar (LNSR)?

The gross profit of Lensar (LNSR) is $6,266,000 on a trailing twelve months (TTM) basis.

What is the operating income of Lensar (LNSR)?

The operating income of Lensar (LNSR) is -$1,245,000.

What is the primary technology used by Lensar Inc?

Lensar Inc specializes in femtosecond laser technology integrated with advanced imaging and augmented reality. This proprietary system is designed specifically for refractive cataract surgery, enhancing surgical precision and patient outcomes.

How does Lensar Inc generate its revenue?

The company generates revenue mainly from the direct sale of its laser systems and related consumable components used in cataract procedures, along with comprehensive service and support to its global customer base.

What distinguishes Lensar Inc's laser system from others in the market?

Unlike repurposed technologies, Lensar Inc's system is purpose-built for refractive cataract surgery. Its unique combination of precise imaging, proprietary augmented reality guidance, and an integrated software platform sets it apart from competitors.

What benefits does the augmented reality imaging provide?

The augmented reality component enables the capture of high-resolution 3D ocular images in a single scan, providing surgeons with comprehensive visual data for planning and executing precise incisions. This leads to highly reproducible surgical outcomes and optimized visual results for patients.

In which markets does Lensar Inc operate?

Lensar Inc operates primarily in the United States, with substantial market presence in Europe and Asia. This geographic diversity underscores its commitment to bringing advanced cataract surgery solutions globally.

How does Lensar Inc support surgeons in optimizing surgical outcomes?

The company’s system provides integrated imaging and software tools that enhance procedure planning and execution. By simplifying the workflow and offering precise data, it assists surgeons in achieving consistent and improved patient outcomes.

What are the key areas of focus for Lensar Inc's product portfolio?

Lensar Inc focuses on developing advanced laser systems for cataract surgery, including components such as streamlined laser technology, robust imaging modules, and proprietary software designed to improve surgical efficiency and clinical results.